Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NONALCOHOLIC STEATOHEPATITIS, CONTAINING HYDROQUINONE DERIVATIVE AND OBETICHOLIC ACID
Document Type and Number:
WIPO Patent Application WO/2021/029656
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition containing, as a first active ingredient, 2,3,5-trimethylhydroquinone-1-hexylether or 2,3,5-trimethylhydroquinone-1-hexylether 4-acetate, and obeticholic acid as a second active ingredient, and has an effect of preventing or treating nonalcoholic steatohepatitis by inhibiting steatosis in liver tissues and hepatic lobular inflammation.
Inventors:
KANG JONG KOO (KR)
KANG SUK MO (KR)
KIM HYUN (KR)
KANG SUK MO (KR)
KIM HYUN (KR)
Application Number:
PCT/KR2020/010649
Publication Date:
February 18, 2021
Filing Date:
August 12, 2020
Export Citation:
Assignee:
BIOTOXTECH CO LTD (KR)
International Classes:
A61K31/122; A61K9/24; A61K31/575; A61P1/16
Foreign References:
| KR20170132879A | 2017-12-04 | |||
| JPH0867627A | 1996-03-12 | |||
| KR20160143894A | 2016-12-14 | |||
| KR20180067699A | 2018-06-20 | |||
| JP2009256226A | 2009-11-05 |
Attorney, Agent or Firm:
GHONG-GAN INTERNATIONAL PATENT LAW FIRM (KR)
Download PDF: